Comparison of Dosing and Costs Between Rheumatoid Arthritis Patients Treated With Remicade Versus Orencia.

Trial Profile

Comparison of Dosing and Costs Between Rheumatoid Arthritis Patients Treated With Remicade Versus Orencia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2012

At a glance

  • Drugs Abatacept; Infliximab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 07 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top